How Atreo Handles Oncology Complexities

Managing supply chains and mid-study protocol amendments in complex oncology trials requires exceptional system flexibility to protect patient timelines and study budgets.

In oncology clinical research, trials rarely progress without RTSM system changes. Patient needs, complex dosing regimens, and evolving protocol design often require dynamic supply models that legacy IRT platforms struggle to support seamlessly.

Eliminating Supply Chain Rigidity in Oncology Studies

A major operational hurdle in trial execution is rigid site sourcing. Atreo solves this by providing versatile sourcing models that adapt to each site's infrastructure:

• On-site Inventory: Direct sourcing from local site supplies.
• Central Pharmacy Sourcing: Direct-to-site fulfillment managed through central pharmacies.
• Hybrid Models: Combined workflows where specific kit types are fulfilled locally while others arrive via central distribution.

This flexible configuration ensures clinical sites operate efficiently without forcing teams into an all-or-nothing supply architecture.

Rapid Mid-Study Mid-Course Corrections in Complex Oncology Trials

Mid-study changes are often the biggest operational pain point in clinical trial management. In complex oncology trials, traditional change order processes demand weeks of fee negotiations, scope reviews, resource scheduling, and repetitive UAT cycles. When patients are waiting for life-saving therapies, these administrative delays are unacceptable.

Atreo streamlines protocol adjustments through dynamic platform capabilities:

• Agile Pivoting: Protocol modifications are executed in minutes or days rather than weeks or months.
• No Change-Order Friction: System updates occur without lengthy pricing negotiations or scope delays.
• Self-Service Controls: Modern tools enable sponsor and study teams to make real-time updates directly.
• Validated Configuration Engine: Rapid implementation ensures audit readiness and compliance throughout the trial lifecycle.

By removing friction commonly accepted with other systems, trial sponsors can simplify complex supply requirements while keeping patient care at the center of study operations. Learn more about Atreo's RTSM platform features to see how modern architecture transforms study execution.